Clinical Trials on Visual Evoked Potentials in New Zealand
Total 2630 results
-
Hospital for Special Surgery, New YorkCompletedEvoked Potentials, VisualUnited States
-
Daiichi Sankyo, Inc.CompletedEffect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)Drug Interaction PotentialUnited States, New Zealand, Taiwan, Netherlands
-
Viatris Specialty LLCCompletedAbuse PotentialUnited States
-
Viatris Specialty LLCCompletedAbuse PotentialUnited States
-
Icahn School of Medicine at Mount SinaiNYC Health + HospitalsCompletedPotentially Inappropriate MedicationsUnited States
-
Alios Biopharma Inc.Completed
-
Gilead SciencesCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
University of Auckland, New ZealandCompletedVaccinationNew Zealand
-
Gilead SciencesCompletedHepatitis C Virus InfectionNew Zealand
-
Assembly BiosciencesNot yet recruitingRecurrent Genital Herpes Simplex Type 2New Zealand
-
Enanta Pharmaceuticals, IncNovotech (Australia) Pty LimitedCompletedHepatitis CNew Zealand
-
Alios Biopharma Inc.TerminatedHepatitis B | Chronic Hepatitis B | Viral Hepatitis BNew Zealand
-
Assembly BiosciencesCompletedChronic Hepatitis BNew Zealand
-
Janssen Research & Development, LLCTerminatedHealthy | Hepatitis B, ChronicNew Zealand
-
Akesobio Australia Pty LtdCompletedCoronavirus Disease 2019 (COVID-19)New Zealand
-
Hoffmann-La RocheCompletedHepatitis C, Chronic, Healthy VolunteerNew Zealand
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedColorectal Cancer | Neoplasm of Uncertain Malignant PotentialUnited States
-
Qilu Pharmaceutical Co., Ltd.Unknown
-
Novartis PharmaceuticalsTerminated
-
Gilead SciencesCompletedChronic Hepatitis CNew Zealand
-
Jiangsu Rec-Biotechnology Co., Ltd.Iqvia Pty LtdCompleted
-
Gilead SciencesCompleted
-
Enanta Pharmaceuticals, IncTerminatedChronic Hepatitis B Virus InfectionNew Zealand
-
Gilead SciencesCompleted
-
Assembly BiosciencesCompletedChronic Hepatitis BNew Zealand
-
Arbutus Biopharma CorporationRecruitingChronic Hepatitis bNew Zealand
-
Yale UniversityCompletedPotential Applications for Heart Failure | Volume OverloadUnited States
-
Antipodean Pharmaceuticals, Inc.Completed
-
Vertex Pharmaceuticals IncorporatedCompletedHepatitis C | Chronic Hepatitis C | HCV | CHCNew Zealand
-
Arrowhead PharmaceuticalsTerminated
-
Assembly BiosciencesCompleted
-
Gilead SciencesCompletedChronic Hepatitis C InfectionNew Zealand
-
Novira Therapeutics, Inc.CompletedChronic Hepatitis BNew Zealand
-
Virion TherapeuticsRecruitingChronic Hepatitis BHong Kong, New Zealand
-
Aligos TherapeuticsTerminatedChronic Hepatitis BUnited Kingdom, New Zealand
-
Arrow TherapeuticsDDS, Dundee; David Mutimer, Birmingham; Ed Gane, ACS New ZealandTerminatedChronic Hepatitis CNew Zealand, United Kingdom
-
Valneva Austria GmbHCompletedSARS-CoV-2 InfectionNew Zealand, Netherlands
-
NovartisNovartis PharmaceuticalsCompletedHepatitis BHong Kong, Singapore, New Zealand
-
Hoffmann-La RocheCompletedHepatitis B, ChronicNew Zealand
-
Gilead SciencesCompletedChronic Hepatitis BUnited States, New Zealand
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Poland, France
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Australia
-
Soroka University Medical CenterEiger BioPharmaceuticalsActive, not recruitingHepatitis D, ChronicIsrael, New Zealand, Turkey
-
Hoffmann-La RocheTerminatedHepatitis B, ChronicHong Kong, Taiwan, New Zealand
-
Eiger BioPharmaceuticalsCompletedHepatitis D, ChronicIsrael, New Zealand, Pakistan
-
Trek Therapeutics, PBCCompletedChronic Hepatitis C | Hepatitis C Genotype 1 | Hepatitis C (HCV) | Hepatitis C Viral InfectionUnited States, New Zealand
-
Arbutus Biopharma CorporationCompletedHepatitis B, ChronicAustralia, New Zealand
-
Syneos HealthF-star Therapeutics, Inc.CompletedHepatitis C InfectionAustralia, New Zealand